We are live on ! Find out more
AIP

ARS Investment Partners Portfolio holdings

AUM $2.29B
1-Year Est. Return 113.95%
This Fund
S&P 500
This Quarter Est. Return
+21.56%
1 Year Est. Return
+113.95%
3 Year Est. Return
+260.1%
5 Year Est. Return
+332.48%
10 Year Est. Return
+1,634.5%
AUM
$552M
AUM Growth
+$79.9M
Cap. Flow
-$6.06M
Cap. Flow %
-1.1%
Top 10 Hldgs %
41.07%
Holding
120
New
8
Increased
25
Reduced
72
Closed
5

Top Buys

Rank Stock Value
1
SWKS icon
Skyworks Solutions
SWKS
+$11.4M
2
CELG
Celgene Corp
CELG
+$10.9M
3
LRCX icon
Lam Research
LRCX
+$7.84M
4
MLM icon
Martin Marietta Materials
MLM
+$5.21M
5
EBIX
Ebix Inc
EBIX
+$3.88M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$7.81M
2
AEP icon
American Electric Power
AEP
+$6.25M
3
NWL icon
Newell Brands
NWL
+$5.69M
4
OLED icon
Universal Display
OLED
+$5.59M
5
ZS icon
Zscaler
ZS
+$4.87M

Sector Composition

Rank Sector Weight
1 Technology 29.67%
2 Communication Services 14.88%
3 Healthcare 11.35%
4 Energy 7.38%
5 Financials 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KTOS icon
101
Kratos Defense & Security Solutions
KTOS
$10.4B
$288K 0.05%
18,450
-70,984
-79% -$1.12M
IBB icon
102
iShares Biotechnology ETF
IBB
$9.44B
$282K 0.05%
2,520
-1,578
-39% -$173K
ED icon
103
Consolidated Edison
ED
$39.7B
$262K 0.05%
3,095
– –
ITA icon
104
iShares US Aerospace & Defense ETF
ITA
$14.8B
$261K 0.05%
2,616
-1,738
-40% -$170K
GPX
105
DELISTED
GP Strategies Corp.
GPX
$239K 0.04%
19,663
-27,400
-58% -$400K
REM icon
106
iShares Mortgage Real Estate ETF
REM
$536M
$236K 0.04%
5,447
– –
NVS icon
107
Novartis
NVS
$293B
$231K 0.04%
2,678
– –
HBIO icon
108
Harvard Bioscience
HBIO
$28.9M
$220K 0.04%
5,116
-11,312
-69% -$410K
AAWW
109
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$216K 0.04%
4,265
-8,700
-67% -$440K
IYC icon
110
iShares US Consumer Discretionary ETF
IYC
$1.21B
$215K 0.04%
4,216
-2,672
-39% -$131K
IWF icon
111
iShares Russell 1000 Growth ETF
IWF
$128B
$211K 0.04%
+5,572
New +$200K
AWK icon
112
American Water Works
AWK
$26.4B
$209K 0.04%
+2,000
New +$196K
BB icon
113
BlackBerry
BB
$5.19B
$209K 0.04%
20,700
-2,600
-11% -$21.9K
WIFI
114
DELISTED
Boingo Wireless, Inc.
WIFI
$204K 0.04%
8,755
-21,125
-71% -$481K
STGW icon
115
Stagwell
STGW
$2.21B
$194K 0.04%
86,060
– –
AIN icon
116
Albany International
AIN
$1.76B
– –
-10,840
Closed -$677K
CLAR icon
117
Clarus
CLAR
$130M
– –
-60,262
Closed -$607K
K
118
DELISTED
Kellanova
K
– –
-54,264
Closed -$2.9M
KHC icon
119
Kraft Heinz
KHC
$30.5B
– –
-8,095
Closed -$348K
PAF
120
DELISTED
Invesco FTSE RAFI Asia Pacific ex-Japan ETF
PAF
– –
-10,850
Closed -$520K
1 2 3 4
5

Similar funds

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
LFM
LGT Fund Management Vaduz, Liechtenstein $2.3B AUM 22.66% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.31B AUM 10.09% 1-Year Est. Return

ARS Investment Partners's Q1 2019 Portfolio in Review

As of Q1 2019, ARS Investment Partners held 120 positions worth $552M, up 17% from $473M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

ARS Investment Partners's Q1 2019 filing shows 8 new, 25 increased, 72 reduced and 5 closed positions. Its largest new stake was Skyworks Solutions: 147,652 shares worth $12.2M. The largest sale was Bristol-Myers Squibb, an estimated $7.81M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 24% a quarter earlier, followed by Communication Services and Healthcare.

  • ARS Investment Partners's largest Q1 2019 buy was Skyworks Solutions: 147,652 shares worth $12.2M.
  • ARS Investment Partners added most to Lam Research in Q1 2019, an estimated $7.84M increase.
  • ARS Investment Partners's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $7.81M.
  • ARS Investment Partners fully exited Kellanova in Q1 2019, selling an estimated $2.9M.
  • ARS Investment Partners's ten largest holdings make up 41% of its $552M portfolio in Q1 2019.
  • ARS Investment Partners opened 8 new positions and closed 5 in Q1 2019.
  • ARS Investment Partners's portfolio value rose 17% quarter-over-quarter to $552M.

Based on ARS Investment Partners's 13F filing for Q1 2019, filed 9 May 2019.